John Flavin, Portal Innovations founder and CEO, joins ‘Squawk on the Street’ to discuss the pharmaceutical themes to focus on in 2026.
Rare disease and neural will have a big year in pharma, says Portal Innovations’ John Flavin
John Flavin, Portal Innovations founder and CEO, joins ‘Squawk on the Street’ to discuss the pharmaceutical themes to focus on in 2026.